This study is the first to demonstrate that WRS could alleviate ARDS through gut-lung axis and provides an alternative therapeutic strategy for the treatment of lung disease.
This dataset contains derivative analysis results generated from the original GWAS summary statistics of the ThyroidOmics Consortium. It includes processed multi-omics data, supplementary figures, and
*All COPD patients were non-smokers for at least 6 months prior to study entry. #Fewer sequences were obtained from COPD samples than from Control samples (p = 0.0326); this association was driven by
